Dr. Mohd Wasim Nasser
My Social Links

Dr. Mohd Wasim Nasser

Research Scientist
Ohio State University, USA


Highest Degree
Ph.D. in Molecular Sciences from The Ohio State University, USA

Share this Profile

Area of Interest:

Molecular Sciences
100%
Molecular Biology
62%
Immunology
90%
Protein Chemistry
75%
Cell Biology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Preet, A., Z. Qamri, M.W. Nasser, A. Prasad and K. Shilo et al., 2011. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of Non-small cell lung cancer growth and metastasis. Cancer Prev. Res., 4: 65-75.
  2. Nasser, M.W., Z. Qamri, Y.S. Deol, D. Smith, K. Shilo, K. Zou and R.K. Ganju, 2011. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion. PLoS One, Vol 6. 10.1371/journal.pone.0023901.
    CrossRef  |  
  3. Deol, Y.S., M.W. Nasser, L. Yu, X.G. Zou and R.K. Ganju, 2011. Tumor suppressive effects of psoriasin (S100A7) are mediated through β catenin/TCF4 pathway in estrogen receptor positive breast cancer cells. J. Biol. Chem, (In Press). 10.1074/jbc.M111.225466.
    CrossRef  |  PubMed  |  
  4. Qamri, Z., A. Preet, M.W. Nasser, B.E. Caroline, G. Leone, S.H. Barsky and R.K. Ganju, 2009. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Mol. Cancer Ther., 8: 3117-3129.
    Direct Link  |  
  5. Nasser, M.W., S.K. Raghuwanshi, D.J. Grant, V.R. Jala, K. Rajarathnam and R.M. Richardson, 2009. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimmer. J. Immunol., 183: 3425-3432.
    CrossRef  |  
  6. Bai, S., M.W. Nasser, B. Wang, S.H. Hsu and J. Datta et al., 2009. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J. Biol. Chem., 284: 32015-32027.
    CrossRef  |  
  7. Raghuwanshi, S.K., M.W. Nasser, X. Chen, R.M. Strieter and R.M. Richardson, 2008. Depletion of β-Arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. J. Immunol., 180: 5699-5706.
    Direct Link  |  
  8. Nasser, M.W., J. Datta, H. Kutay, T. Motiwala and J. Nuovo et al., 2008. Downregulation of microRNA-1 (miR-1) in lung cancer: Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin induced apoptosis by miR-1. J. Biol. Chem., 283: 33394-33405.
  9. Datta, J., H. Kutay, M.W. Nasser, G. Nuovo and B. Wang et al., 2008. Methylation mediated silencing of MicroRNA-1-1 gene in hepatocellular carcinoma: Role of miR-1 as negative regulator of tumor cell growth. Cancer Res., 68: 5049-5058.
    PubMed  |  
  10. Nasser, M.W., S.K. Raghuwanshi, K.M. Malloy, P. Gangavarupu, J.Y. Shim, K. Rajarathnam and R.M. Richardson, 2007. Structural determinants of CXCR1 and CXCR2 involved in receptor activation and downregulation: Role of Aspartic acid 199 of CXCR2 in CXCL8-mediated receptor internalization. J. Biol. Chem., 282: 6906-6915.
  11. Brown, S.L., V.R. Jala, S.K. Raghuwanshi, M.W. Nasser, B. Haribabu and R.M. Richardson, 2006. Activation and regulation of platelet-activating factor receptor: role of G (i) and G (q) in receptor-mediated chemotactic, cytotoxic and cross-regulatory signals. J. Immunol., 177: 3242-3249.
    PubMed  |  
  12. Nasser, M.W., R.J. Marjoram, S.L. Brown and R.M. Richardson, 2005. Cross-desensitization amongst CXCR1, CXCR2 and CCR5: Role of protein kinase C-epsilon. J. Immunol., 174: 6927-6933.
    PubMed  |  
  13. Pooja, V., M.Z. Abidin and S.K. Jain, 2003. Evaluation of Yeast as an expression system. Ind. J. Biotech., 2: 477-493.
  14. Nasser, M.W., T. Hamid and S.K. Jain, 2002. Pathogenesis of Salmonella: Immunological considerations and vaccines. Proc. Natl. Acad. Sci. (India), 72: 135-164.